Walgreens Closes Stores While CVS Expands in Suburban Pharmacies
CVS is gaining market share as Walgreens closes approximately 1,200 stores across the U.S. by 2027 and transitions to private ownership under Sycamore Partners for $10 billion. The closures are attributed to declining pharmacy reimbursements, reduced retail traffic, and competition from Amazon Pharmacy. As a result of regulatory requirements mandating prescription transfers when pharmacies close, many customers end up at nearby CVS locations, allowing the company to absorb business without aggressive marketing or price wars. CVS has benefited structurally due to its vertically integrated model through Caremark, one of the top pharmacy benefit managers in the U.S. This advantage helped drive strong second-quarter 2026 results with over $106 billion in revenue and a 35% increase in operating income compared to last year. CVS executives attribute this growth to improved service and pricing strategies. The shift is reshaping local retail dynamics, reducing consumer choice for prescriptions and everyday items while consolidating convenience spending at surviving stores.
Tickers: $CVS
Topics: pharmaceuticals private equity acquisition retail store closures